Assuming that CREB has been identified as one of the most relevant transcription factors in AML, driving both growth and survival (5, 9), we supposed that CREB transcription factor might be involved in the antiproliferative action made by GSKJ4 in AML cells. Here, CREB1 is linked to acute myeloid leukemia.